Pinnacle Wealth Planning Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$706 Hold
201
﹤0.01% 2595
2025
Q4
$677 Buy
+201
New +$522 ﹤0.01% 2625
2022
Q4
Sell
-10,603
Closed -$109K 470
2022
Q3
$109K Sell
10,603
-60
-0.6% -$680 0.02% 358
2022
Q2
$123K Buy
+10,663
New +$126K 0.02% 371
2022
Q1
Sell
-10,494
Closed -$122K 458
2021
Q4
$122K Sell
10,494
-62
-0.6% -$761 0.02% 391
2021
Q3
$138K Buy
10,556
+160
+2% +$2.07K 0.03% 345
2021
Q2
$134K Buy
10,396
+44
+0.4% +$504 0.03% 335
2021
Q1
$116K Buy
10,352
+9,723
+1,546% +$103K 0.03% 319
2020
Q4
$7K Buy
+629
New +$6.88K ﹤0.01% 1529

Other funds holding IRWD

Pinnacle Wealth Planning Services's IRWD Position: Q1 2026 in Review

Pinnacle Wealth Planning Services held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 201 shares worth $706. The position accounts for ﹤0.01% of the portfolio, ranked #2595.

Pinnacle Wealth Planning Services first reported a position in IRWD in Q4 2020 and has held it in 9 quarters since. The position peaked at $138K in Q3 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Pinnacle Wealth Planning Services held 201 shares of Ironwood Pharmaceuticals worth $706 as of Q1 2026.
  • Pinnacle Wealth Planning Services left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #2595 holding.
  • Pinnacle Wealth Planning Services first reported a position in Ironwood Pharmaceuticals in Q4 2020 and has held it in 9 quarters since.
  • Pinnacle Wealth Planning Services's Ironwood Pharmaceuticals position peaked at $138K in Q3 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.